1) ) Overview of the research programs in the Laboratory of Hepatitis Viruses (LIR) and the Laboratory of Vector-Borne Viral Diseases (LVVD), Division of Viral Products, Office of Vaccines Research and Review, CBER, FDA

2) Recommendations on the selection of strains to be included in an influenza virus vaccine for the 2020 southern hemisphere influenza season

1) Pediatric-focused safety review of OxyContin (oxycodone)

2) Considerations for opioid analgesic pediatric studies and labeling

Pediatric-focused safety review of neuropsychiatric events with use of Singulair (montelukast)

A new drug application (NDA) by GlaxoSmithKline Consumer Healthcare Holdings for over-the-counter nicotine oral spray